<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27828652</article-id>
      <article-id pub-id-type="pmc">5087237</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20165142</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Images in Tropical Dermatology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Response of chromoblastomycosis to voriconazole<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>de Lima</surname>
            <given-names>Alexandre Moretti</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sacht</surname>
            <given-names>Gabriely Lessa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Paula</surname>
            <given-names>Lauren Zogbi Pereira</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aseka</surname>
            <given-names>Gabriela Kimie</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Goetz</surname>
            <given-names>Hermann Soares</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gheller</surname>
            <given-names>Maicon Felippe</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Torraca</surname>
            <given-names>Pedro de Freitas Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Universidade Federal de Mato Grosso do Sul (UFMS) &#x2013; Campo
Grande (MS), Brazil</aff>
      <aff id="aff2"><label>2</label>Hospital de Doen&#xE7;as Tropicais de Goi&#xE1;s
(HDT) &#x2013; Goi&#xE2;nia (GO), Brazil</aff>
      <author-notes>
        <corresp id="c1">Mailing address: Alexandre Moretti de Lima, Av. Sen. Filinto
M&#xFC;ller, 1 Pioneiros, 79080-190 - Campo Grande, - MS Brazil. E-mail:
<email>morettilima@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>5</issue>
      <fpage>679</fpage>
      <lpage>681</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <copyright-holder>Anais Brasileiros de Dermatologia</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Chromoblastomycosis is a chronic fungal infection of the epidermis, dermis and
subcutaneous tissue, in which the most common etiologic agent in Brazil is
<italic>Fonsecaea pedrosoi</italic>. In more advanced cases we found many
difficulties in their treatment, and therefore, we report a case of extensive
and severe chromoblastomycosis, with therapeutical failure of first choice
treatments, but good response to voriconazole.</p>
      </abstract>
      <kwd-group>
        <kwd>Antifungal agents</kwd>
        <kwd>Chromoblastomycosis</kwd>
        <kwd>Fungi</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Male, Caucasian, 48 years old, rural worker, after an accident with a tree branch, for
the last five years has had onset of pruritus and nodular lesion on the lower left limb
and lumbar region, evolving to progressive increase in erythematous verrucous plaques
with areas of atrophy (<xref ref-type="fig" rid="f1">Figure 1</xref>). It was then
diagnosed as chromoblastomycosis by <italic>Fonsecaea pedrosoi</italic>. Since the
diagnosis, during these five years the patient has undergone many treatments such as:
cryosurgery; stand alone itraconazole or in combination with thermotherapy; cryosurgery
and terbinafine; and itraconazole associated with terbinafine, all of them not providing
apparent clinical response. In his last medical visit, patient was hospitalized and
received voriconazole 200mg every 12 hours and, in four weeks of treatment, a
significant improvement of lesions was observed, recovering movement of left knee (<xref ref-type="fig" rid="f2">Figures 2</xref>, <xref ref-type="fig" rid="f3">3</xref> and
<xref ref-type="fig" rid="f4">4</xref>).</p>
    <p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Verrucous plaques with meliceric-hematic crusts on the buttock and left lower
limb</p>
        </caption>
        <graphic xlink:href="abd-91-05-0679-g01"/>
      </fig>
    </p>
    <p>
      <fig id="f2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Weekly clinical evolution of verrucous lesions during 30 days of
hospitalization</p>
        </caption>
        <graphic xlink:href="abd-91-05-0679-g02"/>
      </fig>
    </p>
    <p>
      <fig id="f3" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Acute flattening of verrucous plaques after 12 months of treatment with
voriconazole (200mg orally every 12 hours).</p>
        </caption>
        <graphic xlink:href="abd-91-05-0679-g03"/>
      </fig>
    </p>
    <p>
      <fig id="f4" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Marked improvement of verrucous lesions after 12 months of treatment (side
view)</p>
        </caption>
        <graphic xlink:href="abd-91-05-0679-g04"/>
      </fig>
    </p>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Voriconazole, a new second-generation triazole, which has been effective in cases of
cerebral and disseminated phaeohyphomycosis, demonstrated activity <italic>in
vitro</italic> against the main etiological agents of chromoblastomycosis, such
as <italic>Fonsecaea pedrosoi, Fonsecaea monophora, Fonsecaea nubica and
Cladophialophora carrionii</italic>.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> Similar to
voriconazole, posaconazole and isavuconazole seem to be potential candidates for use
in treatment of chromoblastomycosis, for they present the lowest minimal inhibitory
concentrations in studies with specimens of <italic>Fonsecaea</italic>. However,
only posaconazole is commercially available in Brazil since 2015.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> It is important to highlight the improvement of clinical
conditions and quality of life of these patients, who are resistant to conventional
therapeutics, with these new medications. However, clinical suspicion and early
therapy in initial cases are still paramount for therapeutic success.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at Hospital Universit&#xE1;rio Maria Aparecida Pedrossian
-Universidade Federal de Mato Grosso do Sul (HUMAP-UFMS) &#x2013; Campo Grande (MS),
Brazil. </p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Klompas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marty</surname>
              <given-names>FM</given-names>
            </name>
          </person-group>
          <article-title>Fonsecaea monophora cerebralphaeohyphomycosis: case report of
successful surgical excision and voriconazole treatment and
review</article-title>
          <source>Med Mycol</source>
          <year>2010</year>
          <volume>48</volume>
          <fpage>769</fpage>
          <lpage>774</lpage>
          <pub-id pub-id-type="pmid">20100141</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Queiroz-Telles</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Challenges in the Therapy of Chromoblastomycosis</article-title>
          <source>Mycopathologia</source>
          <year>2013</year>
          <volume>175</volume>
          <fpage>477</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="pmid">23636730</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomes</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Bastos</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Cruz</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Francesconi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Chromoblastomycosis: an exuberant case</article-title>
          <source>An Bras Dermatol</source>
          <year>2014</year>
          <volume>89</volume>
          <fpage>351</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">24770521</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Criado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Valente</surname>
              <given-names>NY</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Belda</surname>
              <given-names>W</given-names>
              <suffix>Junior</suffix>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Dermatite verrucosa de Pedroso e Gomes (Cromomicose): 90 anos
depois, ainda entre n&#xF3;s</article-title>
          <source>An Bras Dermatol</source>
          <year>2010</year>
          <volume>85</volume>
          <fpage>104</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">20464098</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Najafzadeh</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Badali</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Illnait-Zaragozi</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>De Hoog</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Meis</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>In vitro activities of eight antifungal drugs against 55 clinical
isolates of Fonsecaea spp</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>1636</fpage>
          <lpage>1638</lpage>
          <pub-id pub-id-type="pmid">20086140</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
